A publicly available DNA microarray dataset revealed that three of the candidates (PGM1, FNDC3B, and IGF2R) were aberrantly expressed in cervical cancer tissues relative to normal cervix tissues (Fig. 1c). This evidence concerns the gene IGF2R and cervical carcinoma.